These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Atrophy of the skin. The clinical problems. Sneddon IB Br J Dermatol; 1976 Mar; 94 suppl 12():121-3. PubMed ID: 1268072 [No Abstract] [Full Text] [Related]
6. Side effects of potent topical corticosteroids. Jackson R Can Med Assoc J; 1978 Jan; 118(2):173-4. PubMed ID: 93507 [No Abstract] [Full Text] [Related]
7. Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid. Lavker RM; Kaidbey K; Leyden JJ J Am Acad Dermatol; 1992 Apr; 26(4):535-44. PubMed ID: 1597538 [TBL] [Abstract][Full Text] [Related]
8. Assessment of atrophogenicity of popularly prescribed topical corticosteroids. Dykes PJ; Marks R; Blakemore CB Br J Clin Pract; 1978 Dec; 32(12):345-8. PubMed ID: 737113 [No Abstract] [Full Text] [Related]
13. Current dangers and problems in the topical use of steroids. Deakin MJ Med J Aust; 1976 Jan; 1(5):120-1. PubMed ID: 772378 [TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid action on skin collagen: overview on clinical significance and consequences. Nuutinen P; Autio P; Hurskainen T; Oikarinen A J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):361-2. PubMed ID: 11730056 [No Abstract] [Full Text] [Related]
15. The use and abuse of topical corticosteroids. Catterall MD J R Nav Med Serv; 1977; 63(1):18-25. PubMed ID: 864627 [No Abstract] [Full Text] [Related]
17. The measurement of corticosteroid induced dermal atrophy by a radiological method. Marks R; Dykes PJ; Roberts E Arch Dermatol Res (1975); 1975 Sep; 253(2):93-6. PubMed ID: 1190837 [TBL] [Abstract][Full Text] [Related]